341 related articles for article (PubMed ID: 33559412)
21. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
22. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma.
Wu Y; Wang J; Ge L; Hu Q
Oxid Med Cell Longev; 2022; 2022():5130648. PubMed ID: 35251475
[TBL] [Abstract][Full Text] [Related]
23. Tumor Microenvironment CD8 T and Treg Cells-related Genes Signature Distinguishes Distinct Prognosis and Targeted Therapies Response in Endometrial Cancer.
Liu X; Feng D; Wang W; Liang J; Yu H; Ling B
J Immunother; 2023 Jun; 46(5):178-191. PubMed ID: 37098928
[TBL] [Abstract][Full Text] [Related]
24. Nomogram based on autophagy related genes for predicting the survival in melanoma.
Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
[TBL] [Abstract][Full Text] [Related]
25. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
Wang Y; Zhang L; Wang B; Cheng Y
Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
[TBL] [Abstract][Full Text] [Related]
26. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
Jiang P; Sun W; Shen N; Huang X; Fu S
BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
[TBL] [Abstract][Full Text] [Related]
27. An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.
Yu Y; Zhang Y; Li Z; Dong Y; Huang H; Yang B; Zhao E; Chen Y; Yang L; Lu J; Qiu F
BMC Cancer; 2023 Sep; 23(1):879. PubMed ID: 37723477
[TBL] [Abstract][Full Text] [Related]
28. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Zhang Y; Lu H; Zhang J; Wang S
Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Shen R; Liu B; Li X; Yu T; Xu K; Ma J
BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
[TBL] [Abstract][Full Text] [Related]
30. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
31. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
32. A Novel Nomogram Based on Immune Scores for Predicting Survival in Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC).
Wu Z; Ouyang C; Peng L
Med Sci Monit; 2020 Jun; 26():e923231. PubMed ID: 32479428
[TBL] [Abstract][Full Text] [Related]
33. A 15-Gene Signature and Prognostic Nomogram for Predicting Overall Survival in Non-Distant Metastatic Oral Tongue Squamous Cell Carcinoma.
Liu M; Tong L; Liang B; Song X; Xie L; Peng H; Huang D
Front Oncol; 2021; 11():587548. PubMed ID: 33767977
[TBL] [Abstract][Full Text] [Related]
34. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
35. A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.
Cai X; Lin J; Liu L; Zheng J; Liu Q; Ji L; Sun Y
BMC Cancer; 2024 Apr; 24(1):515. PubMed ID: 38654239
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
37. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
[TBL] [Abstract][Full Text] [Related]
38. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
Chen G; Dong Z; Wu D; Chen Y
J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
[TBL] [Abstract][Full Text] [Related]
39. A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
Zhang Z; Weng W; Huang W; Wu B; Zhou Y; Zhang J; Deng T; Ye W; Zhang J; Ao J; Zhang Q; Shi K
Aging (Albany NY); 2020 Jun; 12(13):12896-12920. PubMed ID: 32611831
[TBL] [Abstract][Full Text] [Related]
40. Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer.
Shi R; Li H; Wei S; Yu Z; Zhang J; Zhang Q; Zhou T; Yao Y; Zhang Q; Zhang T; Wang H
BMC Cancer; 2023 May; 23(1):491. PubMed ID: 37259038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]